MP308CLINICAL OUTCOMES ASSOCIATED WITH THE DURATION OF DUAL ANTIPLATELET THERAPY WITH CLOPIDOGREL AND ASPIRIN IN CHRONIC KIDNEY DISEASE PATIENTS WITH ACUTE CORONARY SYNDROME | Zendy

AI Assistant Blog Pricing

MP308CLINICAL OUTCOMES ASSOCIATED WITH THE DURATION OF DUAL ANTIPLATELET THERAPY WITH CLOPIDOGREL AND ASPIRIN IN CHRONIC KIDNEY DISEASE PATIENTS WITH ACUTE CORONARY SYNDROME

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.